Literature DB >> 10085153

High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer.

M A Perrella1, A Pellacani, P Wiesel, M T Chin, L C Foster, M Ibanez, C M Hsieh, R Reeves, S F Yet, M E Lee.   

Abstract

Nitric oxide (NO), a free radical gas whose production is catalyzed by the enzyme NO synthase, participates in the regulation of multiple organ systems. The inducible isoform of NO synthase (iNOS) is transcriptionally up-regulated by inflammatory stimuli; a critical mediator of this process is nuclear factor (NF)-kappaB. Our objective was to determine which regulatory elements other than NF-kappaB binding sites are important for activation of the iNOS promoter/enhancer. We also wanted to identify transcription factors that may be functioning in conjunction with NF-kappaB (subunits p50 and p65) to drive iNOS transcription. Deletion analysis of the iNOS promoter/enhancer revealed that an AT-rich sequence (-61 to -54) downstream of the NF-kappaB site (-85 to -76) in the 5'-flanking sequence was important for iNOS induction by interleukin-1beta and endotoxin in vascular smooth muscle cells. This AT-rich sequence, corresponding to an octamer (Oct) binding site, bound the architectural transcription factor high mobility group (HMG)-I(Y) protein. Electrophoretic mobility shift assays showed that HMG-I(Y) and NF-kappaB subunit p50 bound to the iNOS promoter/enhancer to form a ternary complex. The formation of this complex required HMG-I(Y) binding at the Oct site. The location of an HMG-I(Y) binding site typically overlaps that of a recruited transcription factor. In the iNOS promoter/enhancer, however, HMG-I(Y) formed a complex with p50 while binding downstream of the NF-kappaB site. Furthermore, overexpression of HMG-I(Y) potentiated iNOS promoter/enhancer activity by p50 and p65 in transfection experiments, suggesting that HMG-I(Y) contributes to the transactivation of iNOS by NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085153     DOI: 10.1074/jbc.274.13.9045

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  FGF18 as a prognostic and therapeutic biomarker in ovarian cancer.

Authors:  Wei Wei; Samuel C Mok; Esther Oliva; Sung-hoon Kim; Gayatry Mohapatra; Michael J Birrer
Journal:  J Clin Invest       Date:  2013-09-09       Impact factor: 14.808

2.  Non-NF-kappaB elements are required for full induction of the rat type II nitric oxide synthase in vascular smooth muscle cells.

Authors:  H Zhang; X Teng; C Snead; J D Catravas
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 3.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

Review 4.  The HMG I proteins: dynamic roles in gene activation, development, and tumorigenesis.

Authors:  F Liu; K Y Chau; P Arlotta; S J Ono
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis.

Authors:  Rebecca M Baron; Min-Young Kwon; Ana P Castano; Sailaja Ghanta; Dario F Riascos-Bernal; Silvia Lopez-Guzman; Alvaro Andres Macias; Bonna Ith; Scott L Schissel; James A Lederer; Raymond Reeves; Shaw-Fang Yet; Matthew D Layne; Xiaoli Liu; Mark A Perrella
Journal:  J Leukoc Biol       Date:  2018-07-05       Impact factor: 4.962

Review 6.  The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive.

Authors:  Arindam Dhar; Mathew R Young; Nancy H Colburn
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

7.  Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.

Authors:  Virginie Pétrilli; Zdenko Herceg; Paul O Hassa; Nimesh S A Patel; Rosanna Di Paola; Ulrich Cortes; Laura Dugo; Helder-Mota Filipe; Christoph Thiemermann; Michael O Hottiger; Salvatore Cuzzocrea; Zhao-Qi Wang
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

8.  Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.

Authors:  Rebecca M Baron; Silvia Lopez-Guzman; Dario F Riascos; Alvaro A Macias; Matthew D Layne; Guiying Cheng; Cailin Harris; Su Wol Chung; Raymond Reeves; Ulrich H von Andrian; Mark A Perrella
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

9.  High mobility group A1 protein mediates human nitric oxide synthase 2 gene expression.

Authors:  Rina Takamiya; Rebecca M Baron; Shaw-Fang Yet; Matthew D Layne; Mark A Perrella
Journal:  FEBS Lett       Date:  2008-02-13       Impact factor: 4.124

10.  HMGA1a recognition candidate DNA sequences in humans.

Authors:  Takayuki Manabe; Taiichi Katayama; Masaya Tohyama
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.